These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 1691058
1. CSF and urine biogenic amine metabolites in Rett syndrome. Lekman A, Witt-Engerström I, Holmberg B, Percy A, Svennerholm L, Hagberg B. Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058 [Abstract] [Full Text] [Related]
2. Urinary monoamine metabolites as indices of mental stress in healthy males and females. Frankenhaeuser M, Lundberg U, Rauste von Wright M, von Wright J, Sedvall G. Pharmacol Biochem Behav; 1986 Jun; 24(6):1521-5. PubMed ID: 2426718 [Abstract] [Full Text] [Related]
5. Monoamine metabolites in the CSF of epileptic patients. Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K. Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460 [Abstract] [Full Text] [Related]
6. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage. von Holst H, Lindquist C, Sedvall G. Acta Neurochir (Wien); 1985 Aug; 77(3-4):146-51. PubMed ID: 2416192 [Abstract] [Full Text] [Related]
12. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M. Med Biol; 1985 Oct 01; 63(1):1-17. PubMed ID: 2582215 [Abstract] [Full Text] [Related]
14. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 01; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
15. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Asberg M, Ringberger VA, Sjöqvist F, Thorén P, Träskman L, Tuck JR. Clin Pharmacol Ther; 1977 Feb 01; 21(2):201-7. PubMed ID: 13959 [Abstract] [Full Text] [Related]
16. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression. Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C. Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec 01; 18(8):1261-71. PubMed ID: 7532316 [Abstract] [Full Text] [Related]
17. Amine metabolites in ventricular cerebrospinal fluid in coma. Yates CM, Tsementzis SA, Wilson H. J Neurol Neurosurg Psychiatry; 1979 Oct 01; 42(10):887-91. PubMed ID: 512664 [Abstract] [Full Text] [Related]
18. Reduction of biogenic amine levels in the Rett syndrome. Zoghbi HY, Percy AK, Glaze DG, Butler IJ, Riccardi VM. N Engl J Med; 1985 Oct 10; 313(15):921-4. PubMed ID: 2412119 [Abstract] [Full Text] [Related]
19. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Nordin C. Acta Psychiatr Scand; 1988 Dec 10; 78(6):720-9. PubMed ID: 2464903 [Abstract] [Full Text] [Related]